ArticleAnnals of hematology2026

Addition of rituximab to CEAC conditioning for autologous hematopoietic stem cell transplantation provides no survival benefit in diffuse large B-Cell lymphoma: A propensity score-matched cohort study.

Chaoshuai Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.